Clincosm LogoSign in Get a demo

minimal change disease

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NEPTUNE Match Study

Enrolling by invitation
  • Nephrotic Syndrome in Children
  • +7 more
  • Communication
  • Atlanta, Georgia
  • +15 more
Jan 30, 2023

Focal Segmental Glomerulosclerosis, Minimal Change Disease, Immunoglobulin A Nephropathy Trial in Worldwide (Sparsentan)

Recruiting
  • Focal Segmental Glomerulosclerosis
  • +4 more
  • Wilmington, Delaware
  • +32 more
Jan 10, 2023

Nephrotic Syndrome in Children, Minimal Change Disease, Focal Segmental Glomerulosclerosis Trial in New Hyde Park, Philadelphia

Recruiting
  • Nephrotic Syndrome in Children
  • +2 more
  • Transcutaneous auricular vagus nerve stimulation
  • Sham device
  • New Hyde Park, New York
  • +1 more
Dec 23, 2022

Nephrotic Syndrome in Children, Minimal Change Disease, Focal Segmental Glomerulosclerosis Trial in New Hyde Park, Philadelphia

Recruiting
  • Nephrotic Syndrome in Children
  • +2 more
  • trascutaneous auricular vagus nerve stimulation
  • Sham device
  • New Hyde Park, New York
  • +1 more
Dec 19, 2022

Focal Segmental Glomerulosclerosis and Minimal Change Disease

Not yet recruiting
  • Focal Segmental Glomerulosclerosis
  • +3 more
  • Biospecimen collection
  • Data collection
  • Ann Arbor, Michigan
    University of Michigan
Dec 6, 2022

Adult and Child Patients and Parents of Swelling Due to

Recruiting
  • Fluid Overload
  • +12 more
  • Interview
  • Ann Arbor, Michigan
    University of Michigan
Aug 16, 2022

Minimal Change Disease, Focal Segmental Glomerulosclerosis Trial in United States (VB119)

Recruiting
  • Minimal Change Disease
  • Focal Segmental Glomerulosclerosis
  • Los Angeles, California
  • +7 more
Jul 19, 2022

FSGS, MCD, Focal Segmental Glomerulosclerosis Trial in United States (adalimumab)

Recruiting
  • FSGS
  • +3 more
  • Ann Arbor, Michigan
  • +3 more
Jan 31, 2022

Glomerulosclerosis, Focal Segmental, Minimal Change Disease, Idiopathic Nephrotic Syndrome Trial in Cologne (Biosampling)

Recruiting
  • Glomerulosclerosis, Focal Segmental
  • +2 more
  • Biosampling
  • Cologne, NRW, Germany
    University Hospital of Cologne
Nov 12, 2021

Understand Genetics and Clinical Course of Focal Segmental

Terminated
  • Glomerulosclerosis, Focal Segmental
  • +2 more
  • FSGS/TR-MCD
  • Diabetic Nephropathy (DN)
  • Mesa, Arizona
  • +17 more
Jul 17, 2021

Minimal Change Disease Trial in London (tacrolimus, prednisolone)

Completed
Has Results
  • Minimal Change Disease
  • London, United Kingdom
    Hammersmith Hospital
Apr 9, 2021

Nephrotic Syndrome, Focal Segmental Glomerulosclerosis, Minimal Change Disease Trial in United States (Abatacept, Normal Saline,

Completed
Has Results
  • Nephrotic Syndrome
  • +2 more
  • Birmingham, Alabama
  • +26 more
Feb 10, 2021

Rituximab for Refractory or Relapsed Focal Segmental

Completed
  • Focal Segmental Glomerulosclerosis
  • Minimal Change Disease
    • Istanbul, Turkey
      Istanbul University
    Nov 28, 2020

    Glomerular Disease, Minimal Change Disease, IgA Nephropathy Trial in Chuncheon, Daegu, Seoul (Kidney Biopsy)

    Recruiting
    • Glomerular Disease
    • +6 more
    • Kidney Biopsy
    • Chuncheon, Korea, Republic of
    • +5 more
    Feb 10, 2020

    Idiopathic Nephrotic Syndrome, Minimal Change Disease, Focal Segmental Glomerulosclerosis Trial in Nijmegen (Rituximab,

    Unknown status
    • Idiopathic Nephrotic Syndrome
    • +2 more
    • Nijmegen, Netherlands
      Radboud University Medical Center
    Aug 23, 2018

    Linked Color Imaging for Minimal Change Esophagitis in

    Unknown status
    • Gastroesophageal Reflux Disease
    • +2 more
      • Beijing, Beijing, China
        Department of gastroenterology,Affiliated Hospital to Academy of
      Sep 18, 2017

      Idiopathic Nephrotic Syndrome, Focal Segmental Glomerulosclerosis, Minimal Change Disease Trial in Brussels (Valproic Acid)

      Unknown status
      • Idiopathic Nephrotic Syndrome
      • +2 more
      • Valproic Acid
      • Brussels, Belgium
      • +1 more
      Jun 16, 2017

      Minimal Change Disease Trial in Seoul (Tacrolimus)

      Completed
      • Minimal Change Disease
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Aug 12, 2011